BREXUCABTAGENE AUTOLEUCEL
UNII 4MD2J2T8SJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Brexucabtagene Autoleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4MD2J2T8SJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 2387277. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4MD2J2T8SJ

CAS Registry Number

N/A

RxNorm Concept ID

2387277

Detailed Substance Profile

Preferred Name

BREXUCABTAGENE AUTOLEUCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

4MD2J2T8SJ

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C170439

National Cancer Institute reference terminology for clinical and research data.

INN ID

11886

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-165

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brexucabtagene Autoleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.